Ripping The Bandage Off: GSK Resolves Suits On Many Products For $2.3 Bil.
GlaxoSmithKline's decision to resolve its most onerous litigation in one fell swoop put it among the largest payouts by a pharma company
GlaxoSmithKline's decision to resolve its most onerous litigation in one fell swoop put it among the largest payouts by a pharma company